Sean Lee CFA

Stock Analyst at H.C. Wainwright

(1.09)
# 3,873
Out of 4,649 analysts
264
Total ratings
32.4%
Success rate
-0.6%
Average return
Main Sectors:

Stocks Rated by Sean Lee CFA

Dogwood Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $12
Current: $2.15
Upside: +458.14%
Corvus Pharmaceuticals
Aug 10, 2026
Maintained: Buy
Price Target: $27
Current: $14.89
Upside: +81.33%
Cytosorbents
Aug 7, 2026
Maintained: Hold
Price Target: $0.75
Current: $0.3999
Upside: +87.55%
Senseonics Holdings
Aug 7, 2026
Reiterated: Buy
Price Target: $14
Current: $7.81
Upside: +79.26%
Myomo
Aug 7, 2026
Maintained: Buy
Price Target: $5
Current: $1.72
Upside: +190.70%
Alphatec Holdings
Aug 5, 2026
Maintained: Buy
Price Target: $24
Current: $9.79
Upside: +145.15%
Akari Therapeutics,
Jul 1, 2026
Reiterated: Buy
Price Target: $27
Current: $7.54
Upside: +258.09%
Kazia Therapeutics
Jun 4, 2026
Reiterated: Buy
Price Target: $18
Current: $13.52
Upside: +33.14%
Novavax
Apr 21, 2026
Reiterated: Buy
Price Target: $16
Current: $8.05
Upside: +98.76%
Cerenome
Mar 16, 2026
Reiterated: Buy
Price Target: $25
Current: $3.68
Upside: +579.35%
Maintained: Buy
Price Target: $4
Current: $0.14596
Upside: +2,640.48%
Reiterated: Buy
Price Target: $14
Current: $6.58
Upside: +112.77%
Maintained: Buy
Price Target: €14.00
Current: €3.32
Upside: n/a
Reiterated: Buy
Price Target: $11
Current: $2.18
Upside: n/a
Maintained: Buy
Price Target: $40
Current: $113.04
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a